Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Autologous TIL 1383I TCR transduced T-cells |
Trade Name | |
Synonyms | TIL 1383I T Cell Receptor-Transduced Autologous T cells |
Drug Descriptions |
Autologous TIL 1383I TCR transduced T-cells are patient-derived peripheral blood mononuclear cells engineered to express a T-cell receptor (TCR) targeting melanoma-specific tyrosinase, which potentially induce an increased immune response against tyrosinase-expressing tumors (Journal for ImmunoTherapy of Cancer 2013;1:P31; NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C101787 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Autologous TIL 1383I TCR transduced T-cells | Autologous TIL 1383I TCR transduced T-cells | 0 | 1 |